Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Graphical Abstract 1 Introduction Acute pancreatitis (AP) is a life-threatening inflammatory disorder characterized by premature activation of pancreatic enzymes, leading to autodigestion, edema, hemorrhage, and necrosis of pancreatic tissues (Mederos et al., 2021)
Delgocitinib was recently approved in the European Union and the United Kingdom for treatment of moderate-to-severe CHE, marking a significant step forward in targeted therapy [58, 74]
Monitor blood glucose more carefully
anti-caking agent: silicon dioxide Note: Without flavour enhancers, preservatives and colouring agents
US$ 29.19
US$ 28.26
US$ 21.89
